Disparities in Human Papillomavirus Vaccine Series Completion by Adolescent Males: A Retrospective Cohort Study.
Adolescent
Adolescent Behavior
Black or African American
/ statistics & numerical data
Child
Cohort Studies
Healthcare Disparities
/ ethnology
Humans
Insurance, Health
/ statistics & numerical data
Male
Medicaid
/ statistics & numerical data
Papillomavirus Vaccines
/ therapeutic use
Patient Acceptance of Health Care
/ ethnology
Retrospective Studies
United States
White People
/ statistics & numerical data
Wisconsin
Medicaid
health status disparity
human papillomavirus
immunization
papillomavirus vaccines
socioeconomic factors
Journal
Academic pediatrics
ISSN: 1876-2867
Titre abrégé: Acad Pediatr
Pays: United States
ID NLM: 101499145
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
15
04
2018
revised:
18
04
2019
accepted:
04
05
2019
pubmed:
21
5
2019
medline:
18
3
2021
entrez:
21
5
2019
Statut:
ppublish
Résumé
Human papillomavirus (HPV) vaccine has been recommended for male patients for the prevention of genital warts and precancerous anal lesions since 2009. Our objective was to characterize race and insurance-based disparities in HPV vaccine completion among male patients who initiated the HPV vaccine series. This was a retrospective cohort study of adolescent male patients in a primary care network who initiated the HPV vaccine series from October 2009 to December 2013. We measured vaccine series completion as the primary outcome. We evaluated associations between outcomes and race and insurance status, controlling for potential confounders and effect modification with multivariable logistic regression. Analyses were stratified by vaccine recommendation era (permissive vs routine). In total, 42% of males in the cohort (16,691) completed the vaccine series. In the permissive vaccine era (2009-2011), non-black patients (53%) were more likely to complete than black patients (32%) and non-Medicaid patients (49%) were more likely to complete than Medicaid patients (33%). These differences persisted in the routine recommendation era (2012-2013). In both the permissive and routine eras, Medicaid insurance was associated with a larger reduction in the predicted probability of vaccine series completion for non-black patients. Adherence to the recommended vaccination schedule was low, with a median time to completion of 8.9 months. Using the updated completion schedule (2016), we found that completion rates were greater (54.1%) with continued differences based on race (60% vs 45.7% for non-black vs black patients) and insurance (57.4% vs 46.4% completion for non-Medicaid vs Medicaid patients). We found significant disparities in HPV vaccine series completion rates among male patients based on race and insurance, unchanged based on era of initiation or visit frequency.
Identifiants
pubmed: 31108236
pii: S1876-2859(19)30128-7
doi: 10.1016/j.acap.2019.05.002
pii:
doi:
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
364-373Informations de copyright
Copyright © 2019 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved.